PROBIOTICS (GOOD BACTERIA) TO PREVENT JAUNDICE IN SICK NEWBORN BABIES

PROBIOTICS TO PREVENT MODERATE TO SEVERE JAUNDICE IN AT RISK NREONATES A RANDOMIZED CONTROLLED TRIAL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/10/046339

Enrollment

250

Registered

2022-10-11

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P599- Neonatal jaundice, unspecified

Interventions

Intervention1: PROBIOTICS TO REDUCE INTENSITY OF MODERATE TO SEVERE JAUNDICE IN "AT RISK " NEONATES: PROBIOTICS ARE ADMINISTERED AFTER RANDOMIZATION VS PLACEBO (MULTIVITAMIN DROPS) Control Interventio

Eligibility

Inclusion criteria

Inclusion criteria: LATE PRETERM BABIES(34-37 )WEEKS INFANT OF DIABETIC MOTHERS INTRAUTERINE GROWTH RESTRICTED BABIES

Exclusion criteria

Exclusion criteria: JAUNDICE ON DAY 1 MAJOR CONGENITAL MALFORMATIONS

Design outcomes

Primary

Measure	Time frame
DECREASED INCIDENCE OF MODERATE TO SEVERE JAUNDICETimepoint: 0-7 DAYS OF LIFE	—

Secondary

Measure	Time frame
DECREASED DURATION OF PHOTOTHERAPY DECREASED DURATION OF HOSPITALIZATION TO REDUCE FEED INTOLERANCE Timepoint: 0-7 DAYS OF LIFE	—

Countries

India

Contacts

Public ContactSHIVANI THIRUNAGARI

PARAMITHA CHILDRENS HOSPITAL

shivanithirunagari@gmail.com9912723105

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026